Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee Koski

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|June 14, 2018
Comparative Review of Oral P2Y<sub>12</sub> InhibitorsRenee Koski, Blake Kennedy
Journal of the American Pharmacists Association : Japha|February 5, 2018
Addressing meaningful use and maintaining an accurate medication list in primary careAnne Ottney, Renee Koski
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 7, 2018
Authors' responseRenee Koski, Katelin K Kennedy
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 19, 2017
Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticariaRenee Koski, Katelin K Kennedy
Journal of Pharmacy Practice|August 5, 2016
Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic FungiJacqueline Saunders, Kayla Maki, Renee Koski, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
P & T : a Peer-Reviewed Journal for Formulary Management|June 14, 2018
Comparative Review of Oral P2Y<sub>12</sub> InhibitorsRenee Koski, Blake Kennedy
Journal of the American Pharmacists Association : Japha|February 5, 2018
Addressing meaningful use and maintaining an accurate medication list in primary careAnne Ottney, Renee Koski
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 7, 2018
Authors' responseRenee Koski, Katelin K Kennedy
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 19, 2017
Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticariaRenee Koski, Katelin K Kennedy
Journal of Pharmacy Practice|August 5, 2016
Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic FungiJacqueline Saunders, Kayla Maki, Renee Koski, et al.
Pageof 1